Effectiveness of the Japanese DOLOPLUS-2: a pain assessment scale for patients with moderate-to-severe dementia
Effectiveness of the Japanese DOLOPLUS-2: a pain assessment scale for patients with moderate-to-severe dementia
复制标题
DOI：
10.1111/psyg.12168
复制
发表时间：
2016-09-01
期刊：
影响因子：
2
通讯作者：
Hishinuma, Michiko
中科院分区：
文献类型：
--
作者：
Ando, Chiaki;Ito, Yoshinori;Hishinuma, Michiko
本研究旨在评估日本DOLOPLUS-2量表是否能有效识别中重度痴呆老年患者的疼痛。方法本研究采用目的性抽样的前测/后测设计，选择实验组和历史对照组。纳入标准是功能评估分期评分为5或6分，骨科疾病的诊断通常涉及疼痛，说“我目前感到疼痛”的能力（防止用药错误），以及第一次疼痛评估时DOLOPLUS-2量表总分为5分。实验组（n = 19）于每天下午2点和9点采用DOLOPLUS-2量表进行评估，连续5天。如果患者的总分为5分，则开止痛药，并在大约3小时后对患者进行重新评估。对照组（n = 20）从1年的医疗记录中收集数据，我们将对照组的特征与实验组的特征相匹配。我们还回顾了护理记录，以确定在护士首次记录患者疼痛后5天内给予镇痛药的次数。结果实验组19例患者中，有15例患者因疼痛总分5分而接受了止痛药治疗。治疗前患者的DOLOPLUS-2评分平均为7.5 3.2分，治疗后评分为2.9 +/- 2.1分，差异有统计学意义（P < 0.001）。实验组使用镇痛药物的次数明显多于对照组（(2)= 16.033,P < 0.001, phi = 0.641）。结论本研究结果提示日本DOLOPLUS-2量表能充分识别老年中重度痴呆患者的疼痛。
BackgroundThis study aimed to assess whether the Japanese DOLOPLUS-2 scale could effectively identify pain in elderly individuals with moderate-to-severe dementia.MethodsThis study used a pre-test/post-test design with purposive sampling to select an experimental group and a historical control group. The inclusion criteria were a Functional Assessment Staging score of 5 or 6, a diagnosis of an orthopaedic disease that typically involves pain, the ability to say I am currently in pain' (to prevent medication errors), and a total DOLOPLUS-2 scale score 5 at the first pain assessment. In the experimental group (n = 19), each patient was assessed by the DOLOPLUS-2 scale at 2PM and 9PM each day for 5 days. If a patient's total score was 5, analgesics were prescribed and the patient was re-assessed approximately 3 hours later. In the control group (n = 20), data were collected from medical records over a 1-year period, and we matched the characteristics of the control group to that of the experimental group. We also reviewed nursing records to determine the number of times analgesics had been administered over the 5 days after the nurses had first recorded that the patient had experienced pain.ResultsAmong the 19 patients in the experimental group, 15 received pain medication because of a total pain score 5. Before treatment, their mean DOLOPLUS-2 scale score was 7.5 3.2, and their score significantly decreased to 2.9 +/- 2.1 (P < 0.001) after treatment. The experimental group also received significantly more treatments with analgesic medication than the control group ((2) = 16.033, P < 0.001, phi = 0.641).ConclusionThis study's findings suggested that the Japanese DOLOPLUS-2 scale could adequately identify pain in elderly individuals with moderate-to-severe dementia.